254 related articles for article (PubMed ID: 19156219)
1. Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice.
Zhao Y; Lin B; Darflinger R; Zhang Y; Holterman MJ; Skidgel RA
PLoS One; 2009; 4(1):e4226. PubMed ID: 19156219
[TBL] [Abstract][Full Text] [Related]
2. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
4. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
5. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets.
Montane J; Bischoff L; Soukhatcheva G; Dai DL; Hardenberg G; Levings MK; Orban PC; Kieffer TJ; Tan R; Verchere CB
J Clin Invest; 2011 Aug; 121(8):3024-8. PubMed ID: 21737880
[TBL] [Abstract][Full Text] [Related]
6. Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes.
Huang SH; Kuo SL; Chen SJ; Lin JR; Chen YW; Hong ZJ; Sytwu HK; Lin GJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163121
[TBL] [Abstract][Full Text] [Related]
7. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
[TBL] [Abstract][Full Text] [Related]
8. IDO-Expressing Fibroblasts Protect Islet Beta Cells From Immunological Attack and Reverse Hyperglycemia in Non-Obese Diabetic Mice.
Zhang Y; Jalili RB; Kilani RT; Elizei SS; Farrokhi A; Khosravi-Maharlooei M; Warnock GL; Ao Z; Marzban L; Ghahary A
J Cell Physiol; 2016 Sep; 231(9):1964-73. PubMed ID: 26743772
[TBL] [Abstract][Full Text] [Related]
9. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
11. Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.
Zhao Y; Jiang Z; Zhao T; Ye M; Hu C; Yin Z; Li H; Zhang Y; Diao Y; Li Y; Chen Y; Sun X; Fisk MB; Skidgel R; Holterman M; Prabhakar B; Mazzone T
BMC Med; 2012 Jan; 10():3. PubMed ID: 22233865
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
13. High Thymic Output of Effector CD4
Zhao Y; Alard P; Kosiewicz MM
J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
[TBL] [Abstract][Full Text] [Related]
14. PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
Azzi J; Thueson L; Moore R; Abdoli R; Reijonen H; Abdi R
PLoS One; 2017; 12(1):e0169695. PubMed ID: 28081180
[TBL] [Abstract][Full Text] [Related]
15. [Regulatory T lymphocytes expressing L-selectin in children and adolescents with type 1 diabetes mellitus].
Ryba M; Hak L; Zorena K; Myśliwiec M; Myśliwska J
Pediatr Endocrinol Diabetes Metab; 2010; 16(1):12-6. PubMed ID: 20529600
[TBL] [Abstract][Full Text] [Related]
16. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice.
Lepault F; Gagnerault MC
J Immunol; 2000 Jan; 164(1):240-7. PubMed ID: 10605017
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
Manirarora JN; Wei CH
J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
19. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice.
Hill NJ; Van Gunst K; Sarvetnick N
J Immunol; 2003 Feb; 170(4):1649-58. PubMed ID: 12574327
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice.
Mueller R; Krahl T; Sarvetnick N
J Exp Med; 1996 Sep; 184(3):1093-9. PubMed ID: 9064326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]